Sparrow Acoustics, Inc.

Sparrow Acoustics, Inc. specializes in electronic acoustic stethoscopes. These devices combine traditional auscultation with digital amplification and recording features, such as the Stethophone and Stethophone Pro series. The focus is on enhancing clinician workflow by providing clearer sound capture and playback for patient evaluation.

Sparrow Acoustics, Inc. is based in the United States. As a U.S.-based manufacturer, its devices must comply with FDA regulations. The company’s products fall under the FDA’s Class II classification, which typically requires pre-market notification (510(k)) and Unique Device Identification (UDI) compliance to demonstrate safety and effectiveness before commercial distribution.

Sparrow Acoustics’ devices are listed in the FDA’s 510(k) premarket notification database and the UDI (Unique Device Identification) registry. These listings confirm that the devices have undergone the required regulatory pathways—such as 510(k) clearance—to ensure compliance with U.S. medical device standards before entering the market.

Sparrow Acoustics’ electronic acoustic stethoscopes are classified as Class II medical devices by the FDA. This classification means they pose moderate risk and require specific regulatory controls, such as the 510(k) pathway, to verify their safety and performance. The classification ensures that devices undergo rigorous review to balance innovation with patient safety before authorisation.